Lewy Body Dementia Market Size, Trends, and Growth Analysis 2025-2032

The Lewy Body Dementia market is witnessing considerable evolution driven by advances in therapeutic approaches and rising awareness about neurodegenerative disorders.

Market Size and Overview: 
The Global Lewy Body Dementia Market is estimated to be valued at USD 1.35 Bn in 2025 and is expected to reach USD 2.27 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2032.

Market Segments 
The Lewy Body Dementia market comprises three core segments: 
- Therapeutics: Includes pharmacological treatments such as cholinesterase inhibitors and novel immunotherapy agents. The cholinesterase inhibitor segment remains dominant due to well-established efficacy, whereas immunotherapy is the fastest-growing sub-segment, fueled by breakthroughs reported in 2024 clinical trials. 

- Diagnostics: Broadly categorized into imaging techniques and biomarker assays. Advanced PET imaging accounts for major adoption, while cerebrospinal fluid biomarker testing is gaining traction rapidly due to improved accuracy in differential diagnosis reported in 2025 studies.

- End Users: Hospitals, specialized neurology clinics, and research institutes. Specialized clinics are the dominant segment, reflecting the increasing focus on personalized patient care, but research institutes represent the fastest-growing segment owing to rising clinical research activities and drug development efforts.

‣ Get more insights on: Lewy Body Dementia Market

‣ Get this Report in Japanese Language: レビー小体型認知症市場

‣ Get this Report in Korean Language: 루이소체치매시장